VIPIDIA

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Turkey, United Kingdom

Active ingredients

The drug VIPIDIA contains one active pharmaceutical ingredient (API):

1 Alogliptin UNII EEN99869SC - ALOGLIPTIN BENZOATE

Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high. Read about Alogliptin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIPIDIA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BH04		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1627321, 1627332, 1627343, 1627354, 1627365, 1627376, 1627387, 1627398, 1627400, 1627411, 1627422, 1627433, 1627444, 1627455, 1627466, 1627477, 1627488, 1627499, 1627501, 1627512, 1627523, 1627534, 1627545, 1627556, 1627567, 1627578, 1627589, 1675964, 1675986, 1675997
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 113844003, 113844012, 113844021
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 055726, 095980, 112199, 581871
Country: FR	Base de données publique des médicaments	Identifier(s): 62758742, 64835365, 67556495
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 236342, 236361, 236364, 369064, 375380, 375382, 377092, 377096, 379743, 379777, 381749, 381751, 381753
Country: IT	Agenzia del Farmaco	Identifier(s): 043051010, 043051022, 043051034, 043051046, 043051059, 043051061, 043051073, 043051085, 043051097, 043051109, 043051111, 043051123, 043051135, 043051147, 043051150, 043051162, 043051174, 043051186, 043051198, 043051200, 043051212, 043051224, 043051236, 043051248, 043051251, 043051263, 043051275, 043051287, 043051299, 043051301
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071474, 1071475, 1071476, 1071477, 1071478, 1071479, 1071480, 1071481, 1071482, 1071483, 1071484, 1071485, 1071486, 1071487, 1071488, 1071489, 1071490, 1071491, 1071492, 1071493, 1071494, 1071495, 1071496, 1071497, 1071498, 1071499, 1071500, 1091810, 1091811, 1091812
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100313919, 100313925, 100313931
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699456090011, 8699456090028